|
How to Advertise on Betterchem.com…
Most advertising on this site is managed by Google Adwords. Adwords lets businesses advertise on sites
regardless of their budget. At Betterchem, your Ad campaigns can target keywords and/or the visitor's
geographical location. We do not participate in Adwords targeted campaigns at this time.
|
|
|
|
|
If you would like to target one or more of our network's 200,000 plus pages…
Purchase a banner space for a low monthly fee. Banner spaces on individual pages are available for as little as $50/month. Email sales@betterchem.com. Place "Banner Placement" in the subject line and include our page's URL (where you'd like your banner to appear) in the subject. You need to supply us with links to your banner image and URL for the target page (at your site). We will revert with price and conditions. Betterchem reserves the right to refuse ads that do not meet our editorial standards.
|
|
Free
Ad space for your pharma products.
Simply list your products and create a reciprocal link. See how.
|
| Keywords for the Ads: Protonix I.V.(pantoprazole sodium) Injection, Wyeth-Ayerst NDA 20-988/S7 2/21/03 3/10/03
Protonix I.V. (pantoprazole sodium) for Injection, equivalent to 40 mg, Wyeth-Ayerst NDA 20-988/S-003 Protonix I. V. (pantoprazole sodium) Injection, Wyeth-Ayerst NDA 20-988/S16 10/24/03
Protonix I. V. (pantoprazole sodium) Injection, Wyeth-Ayerst NDA 20-988/S3 10/18/01 11/6/01 11/6/01
Protonix I. V. (pantoprazole sodium) Injection, Wyeth-Ayerst NDA 20-988 3/22/01 4/4/02 4/4/02 4/4/02
Protonix Indication: Short-term treatment (7 to 10 days) of gastroesophageal reflux disease GERD).
Protonix (pantoprazole sodium) Delayed-Release Tablets & IV, Wyeth NDA 20-987/SLR-013 & 20-988/SLR-012 10/28/02 10/30/02 4/9/03
Protonix (pantoprazole sodium) Delayed-Release Tablets, 20 & 40 mg, Wyeth-Ayerst NDA 20-987/S7 4/19/02 5/2/02 4/22/02 7/31/02
Protonix (pantoprazole sodium) Delayed-Release Tablets, Wyeth-Ayerst NDA 20-987/S5 7/20/01 04/25/03
Protonix (pantoprazole sodium) Delayed-Release Tablets, 40 mg, Wyeth-Ayerst NDA 20-987S1 & S2 6/12/01 11/6/01
Protonix Indication: Maintenance of Healing of Erosive Esophagitis and control of daytime and nighttime heartburn symptoms in patients with gastroesophageal reflux disease (GERD).
Protonix (pantoprazole sodium) Delayed-Release Tablets Wyeth-Ayerst NDA 20-987 2/2/00 2/3/00 2/7/00 6/18/01
Protonix Indication: Short-term treatment of erosive esophagitis associated with gastroesophageal reflux disease GERD). Protonix I. V. (pantoprazole sodium) Injection, Wyeth-Ayerst Protonix I.V.(pantoprazole sodium) Injection, Wyeth
© 2008 Betterchem Corp.
|
|
